Natus Medical Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing

NEW YORK, March 4, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Natus Medical Inc. shareholders (NASDAQ: BABY). Concerned BABY investors who purchased between April 23, 2014 and March 2, 2015 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

The law firm's investigation will focus on potential violations of the federal securities laws.  Natus Medical announced on March 3, 2015, material weakness due to aggregation of control deficiencies resulting from a lack of timely risk assessment and monitoring of internal controls. As a result, Natus Medical announced that it would be unable to file its annual report on Form 10-K in a timely manner.  As a result of this announcement, on March 3, 2015, shares of Natus Medical are down $1.31, or almost 4%, currently trading at $34.02.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. BABY stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/BABY.

Find these Waco personal injury attorneys, trucking accident attorneys and car wreck attorneys on Google+, Facebook, Twitter and LinkedIn.

SOURCE Dunnam & Dunnam

Related Links

http://www.dunnamlaw.com